PET-CT Contrast Agent for Tissue Discrimination
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current PET-CT scans face challenges in accurately distinguishing between tumour tissue and brown adipose tissue, leading to false positives and negatives, which can impact cancer diagnosis and prognosis, due to non-specific uptake of 18FDG tracer by brown adipose tissue.
Innovation Solution
Administration of a PET-CT contrast agent, specifically iodinated fatty acids and/or esters, prior to the 18FDG PET-CT scan to enhance differentiation between tumour and brown adipose tissue by providing colocalized signals, allowing for more accurate discrimination and assessment of cancer prognosis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If 18FDG PET-CT scan is used to detect cancer metastases, then sensitivity for identifying malignant sites is improved, but false positive rate increases due to non-specific uptake by brown adipose tissue
Solution Approach 1:
The patent divides the detection task into two separate imaging modalities: PET imaging using 18FDG to detect metabolic activity, and CT imaging to provide anatomical localization. By segmenting the detection function, the system can distinguish between metabolic uptake in brown fat versus actual tumor metabolism, reducing false positives while maintaining sensitivity for cancer detection
Solution Approach 2:
The patent introduces a dual-modality imaging approach where CT serves as an intermediary to validate PET findings. The CT component provides anatomical context that helps differentiate benign brown fat uptake from malignant lesions, acting as a mediator to reduce false positive interpretations of PET data
2Ease of operation
If PET-CT scan relies solely on 18FDG uptake patterns, then simplicity of procedure is maintained, but discrimination between tumour and brown adipose tissue becomes difficult
Solution Approach 1:
The patent merges PET and CT imaging into a single integrated PET-CT system that performs both functional and anatomical imaging in one procedure. This combination maintains procedural simplicity while dramatically improving tissue differentiation accuracy through the complementary information provided by each modality
Solution Approach 2:
The PET-CT system performs multiple functions simultaneously: it detects metabolic activity (PET), provides anatomical localization (CT), and enables tissue characterization by combining both data sets. This multi-functionality allows the system to maintain operational simplicity while achieving superior discrimination between tumor and brown adipose tissue
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of the PET-CT contrast agent improves the accuracy of PET-CT scans by reducing false positives and negatives, enhancing the specificity and sensitivity for tumour metastases and brown adipose tissue, thereby improving cancer diagnosis and prognosis.
Implementation Method 1
18FDG is transported into tumour cells, similarly to glucose, by means of glucose transporter proteins known as GLUT transporters and subsequently phosphorylated by hexokinase to 18FDG 6-phosphate. 18FDG 6-phosphate is not efficiently metabolized further and therefore accumulates within the cell. This process of 'metabolic trapping' of 18FDG in the cell constitutes the basis for imaging the in vivo distribution of the tracer
Implementation Method 2
Positron emission tomography (PET) is an imaging technique that uses radioactive substances to visualize and measure metabolic processes in the body
Implementation Method 3
computed tomography (CT) is a medical imaging procedure that uses computer-processed combinations of several X-ray measurements taken from different angles to produce cross-sectional (tomographic) X-ray images
Implementation Method 4
PET-CT combines a PET scanner and a CT scanner to acquire images from both devices in the same (single) scanning session, which are combined into a single image. Thus, PET-CT allows precise anatomical alignement of functional imaging obtained by PET
Data Source
AI summary
The invention describes a method to differentiate tumour tissue from brown adipose tissue on a PET-CT scan. In particular, the invention concerns a method for discriminating primary tumour and/or metastases from brown and/or beige adipose tissue, by PET-CT imaging, in a human cancer patient.